Phase I trial of UGP 281.
Phase of Trial: Phase I
Latest Information Update: 26 Sep 2012
At a glance
- Drugs UGP 281 (Primary)
- Indications Obesity
- Focus Adverse reactions
- 26 Sep 2012 Unigene has secured funding and is making preparations for an IND filing in 2013 according to a Unigene media release.
- 09 Aug 2012 Plans for this trial have been put on hold due to funding issues according to a Unigene media release.
- 22 May 2012 Planned initiation date changed from 1 Dec 2012 to 1 Jun 2013 as reported by Unigene laboratories.